AMY PHILLIPS: Open Payments
NPI 1447729611 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$888 in 38 payments from 16 companies in 2025. Trend: 2023 $1,237 · 2024 $1,240 · 2025 $888
Food & beverage: $888
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $112 |
| Veloxis Pharmaceuticals, Inc. | 3 | $108 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $92 |
| Otsuka America Pharmaceutical, Inc. | 3 | $89 |
| Travere Therapeutics, Inc. | 4 | $77 |
| Novartis Pharmaceuticals Corporation | 3 | $75 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| Lilly USA, LLC | 2 | $51 |
| AKEBIA THERAPEUTICS INC | 2 | $51 |
| Calliditas Therapeutics US Inc. | 2 | $46 |
Products named: ENVARSUS, Kerendia, JYNARQUE, Fabhalta, TAVNEOS, JARDIANCE, FARXIGA, Vafseo.
Industry payments across TX — which companies pay providers there.
